Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

MIAMI, July 7, 2021 /PRNewswire/ -- Remote critical care and specialist physician services provider Intercept TeleMed, Inc., www.intercepttelemed.com, announced the addition of Richard Boxer MD, a former US Presidential advisor, nationally recognized figure in public health service, and former Chief Medical Officer of Teladoc (NYSE TDOC) to its senior management team. Dr. Boxer is also credited with creating the first medical guidelines for evidence-based telemedicine and industry standards for telemedicine Quality Assurance and Quality Improvement.

Dr. Richard Boxer, MD, Joins Intercept TeleMed Senior Management Team

TDOC looks like it has made a significant bottom. There's much left to do for the bulls, but signs are positive.

Teladoc: Mea Culpa And A Refreshed Outlook

Some investors probably bought the virtual healthcare leader's stock on the belief that its 2021 sell-off has been overdone.

Why Teladoc Stock Jumped 10.4% in June

Pubmatic

These companies are innovators within their respective high-growth industries.

3 Top Stocks That'll Make You Richer in July (and Beyond)

Amazon

Skillz

Sarepta Therapeutics

Analysts are expecting big things from these fast-paced companies over the next 12 months.

5 High-Growth Stocks With 62% to 144% Upside, According to Wall Street

Acadia Healthcare

COMPASS Pathways

Intra-Cellular Therapies

LifeStance Health Group

Mind Medicine MindMed

One of the most devastating long-term impacts of the COVID-19 pandemic may be the toll it has taken on people's mental health. The next global health crisis may be related to mental health issues such as anxiety and depression, and companies that are focused on mental health could be well-positioned to capitalize on the opportunity.

Pandemic Fallout: 6 Mental Health Stocks To Watch

Carnival

United Continental Hlds

Hot stocks are leading the charge in this bullish run. Today we find three of them that may still be hidden gems and under the radar.

3 Hot Stocks to Buy into the Second Half of 2021

Coupa Software

Nutanix

These three companies may not be viral hits, but they could be fantastic wealth generators over the long term.

Forget Meme Stocks, Buy These 3 High-Growth Tech Stocks Instead

Johnson & Johnson

Two promise major growth. One will fill your pockets with dividend payments.

Ignore Biogen: Here Are 3 Better Stocks

American Well Corporation

Clover Health Investments

On its face, it is the perfect marriage of growth and value, of cyclical risk and staple economics. The marriage of technology and healthcare is a potent addition for portfolio strategists and individual investors alike.

The Next Frontier: Technology in the Healthcare Space

The next revolution in healthcare has arrived, and it will become a massive disruptor to this segment of the stock market. The post The Next Revolution in Healthcare appeared first on InvestorPlace.

The Next Revolution in Healthcare

BARK

Fastly

Vertex Pharmaceuticals

These fast-paced companies should be absolute moneymakers over the long term.

5 Growth Stocks I've Bought Over the Past 2 Months

Block

Zoom Video

You can cut out the guesswork by investing in these three top growth stocks.

The Smartest People On Wall Street Are Buying These 3 Stocks -- Should You Follow?

Coinbase

Growth stocks are bouncing back, but these three names are still on sale.

3 Top Stocks That You Can Still Buy at 40% Off

1Life Healthcare

Few trends are as easily identifiable as the structural opportunity in the healthcare technology space. As a society, we have undergone a transformative experience as a society over the past year, with so many taken-for-granted facets of daily life halted, rearranged, and rebuilt in what ultimately may be a superior form.

The Opportunity in Disruptive Healthcare Stocks

Republicans and Democrats want to keep the changes that increased access to telehealth for tens of millions of Americans.

Bipartisanship Could Propel These 2 Hypergrowth Stocks Higher

Trupanion

Unlike Dogecoin, these fast-growing stocks could go to the moon.

Dump Dogecoin: These Growth Stocks Are Ready to Blast Off

We previously passed on the stock due to its stretched valuation and uncertain moat. Since then, the stock price has fallen significantly.

Teladoc Is Starting To Look Interesting

iRobot

Palo Alto Networks

Many trends were accelerated by the Covid-19 health crisis and have now become entrenched in our everyday lives. Looking forward, there are a number of companies that are at the forefront of these life-changing trends.

4 Best Long-Term Stocks to Buy to Profit From Life-Changing Trends

The tech company just isn't a serious competitor, yet.

Why Teladoc Isn't Worried About Amazon Care

UpHealth is trading at a severe discount to peers.

Should You Buy This Upbeat Telehealth Stock?

Crocs

Ocugen, Inc.

Roblox

Schrodinger 

XPeng

Searching for stocks to buy that could legitimately double before 2022? These seven are in position to do just that.

7 Stocks To Buy if You're Trying to Double Your Money in 2021

Even after the coronavirus is in our rearview mirror, Teladoc will still be with us.

Why Teladoc Will Continue to Win

Fulgent Genetics

Wall Street is nervous, but these companies see growth beyond the pandemic.

2 Stocks That Are More Likely to Double Your Money Than Dogecoin

MercadoLibre

Pinterest

Like the popular cryptocurrency, these stocks are beaten down. But they have compelling growth prospects.

News for Teladoc Stock (TDOC)